(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Renaissance Washington DC Dupont Circle Hotel

Oct 25, 2016 7:15 AM - Oct 26, 2016 3:30 PM

Formerly Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW, , Washington, DC 20037 , USA

Combination Products 2016

Current, Evolving, and Future Pathways

Back to Agenda

Keynote Address: Innovation in Medical Product Development: A Regulatory Perspective

Session Chair(s)

John Weiner, JD

John Weiner, JD

Associate Director for Policy, Office of Combination Products, OCPP, OC

FDA, United States

FDA has been taking a close look at how we regulate combination products and regulatory considerations for other combined uses of medical products. Dr. Hunter will be offering remarks on the agency’s vision in this area and efforts FDA is pursuing to break down silos and ensure a consistent, risk-based approach to regulation of combination products and other combined uses of medical products.

Speaker(s)

Nina L Hunter, PhD

Speaker

Nina L Hunter, PhD

FDA, United States

Associate Director for Science Policy, Office of Medical Products and Tobacco

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.